National Blood Center Foundation, Hemolife Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2020
NCT04385186
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

National Blood Center Foundation, Hemolife